Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Regenxbio Inc shares valued at $327,942 were sold by Mills Kenneth T. on Mar 14 ’24. At $21.86 per share, Mills Kenneth T. sold 15,000 shares. The insider’s holdings dropped to 408,035 shares worth approximately $7.81 million following the completion of this transaction.
Also, PAKOLA STEVE sold 12,878 shares, netting a total of over 365,220 in proceeds. Following the sale of shares at $28.36 each, the insider now holds 107,192 shares.
Before that, Mills Kenneth T. had sold 15,000 shares from its account. In a trade valued at $251,349, the President and CEO traded Regenxbio Inc shares for $16.76 each. Upon closing the transaction, the insider’s holdings decreased to 15,000 shares, worth approximately $7.81 million.
As published in their initiating research note from H.C. Wainwright on March 11, 2024, Regenxbio Inc [RGNX] has been a Buy and the price target has been revised to $36. Analysts at RBC Capital Mkts upgraded the stock from ‘”a Sector perform”‘ to ‘”an Outperform”‘ outlook in a report released in early March. As of March 06, 2024, Leerink Partners has increased its “Market perform” rating to a “an Outperform” for RGNX.
Analyzing RGNX Stock Performance
During the last five days, there has been a drop of approximately -13.66%. Over the course of the year, Regenxbio Inc shares have jumped approximately 6.69%. Shares of the company reached a 52-week high of $28.80 on 03/05/24 and a 52-week low of $11.83 on 02/02/24. A 50-day SMA is recorded $18.76, while a 200-day SMA reached $17.97. Nevertheless, trading volume fell to 0.64 million shares from 0.54 million shares the previous day.
Support And Resistance Levels for Regenxbio Inc (RGNX)
According to the 24-hour chart, there is a support level at 18.55, which, if violated, would cause prices to drop to 17.95. In the upper region, resistance lies at 20.26. The next price resistance is at 21.37. RSI (Relative Strength Index) is 40.28 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.63, which suggests the price will decrease in the coming days. Percent R is at 97.79%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
Is Regenxbio Inc subject to short interest?
Stocks of Regenxbio Inc saw a sharp steep in short interest on Mar 15, 2024 dropping by 20000.0 shares to 4.15 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 4.17 million shares. A decline of -0.48% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.89 of the overall float, the days-to-cover ratio (short ratio) decline to 3.89.
